Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D
NCT01638208
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Irritable Bowel Syndrome
Interventions
DRUG:
VSL#3
Sponsor
Asian Institute of Gastroenterology, India